Insight Molecular Diagnostics (IMDX) Intangibles (2015 - 2025)

Insight Molecular Diagnostics has reported Intangibles for 10 years, with the latest figure at $440000.0 in Q4 2025.

• Quarterly Intangibles fell 97.07% year-over-year to $440000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $440000.0 (down 97.07% YoY) and the FY2025 annual result came in at $440000.0, down 97.07% from the prior year.
• Intangibles declined to $440000.0 in Q4 2025 per IMDX's latest filing, from $14.6 million in the prior quarter.
• Over five years, Intangibles peaked at $94.7 million in Q2 2022 and troughed at $440000.0 in Q1 2023.
• A 5-year average of $44.5 million and a median of $56.6 million in 2023 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2024: Intangibles slumped 99.51% in 2023, then jumped 12757.5% in 2024.
• Over 5 years, Intangibles stood at $61.7 million in 2021, then gained by 0.27% to $61.9 million in 2022, then sank by 99.29% to $440000.0 in 2023, then surged by 3318.18% to $15.0 million in 2024, then sank by 97.07% to $440000.0 in 2025.
• According to Business Quant data, Intangibles over the past three periods registered $440000.0, $14.6 million, and $440000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.